|
1. |
Multi-hit nature of chronic renal disease |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 85-97
Vesselin Nenov,
Maarten Taal,
Olga Sakharova,
Barry Brenner,
Preview
|
|
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
2. |
Deciphering diabetic nephropathy: progress using genetic strategies |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 99-106
Sharon Adler,
Madeleine Pahl,
Michael Seldin,
Preview
|
|
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
3. |
Progress in the treatment of proliferative lupus nephritis |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 107-115
James Balow,
Howard Austin III,
Preview
|
|
摘要:
Lupus nephritis is often well developed at the time of diagnosis. High-dose corticosteroids are universally accepted as the initial approach to the control of severe inflammation in the kidney. Long-term disease control and the minimization of iatrogenic risk usually require adjunctive therapies that target the more fundamental immunoregulatory disturbances of lymphoid cells. Of the available cytotoxic drugs, cyclophosphamide is currently among the most effective, although it cannot be considered ideal in terms of efficacy or toxicity. New prospects for the treatment of proliferative lupus nephritis include novel immunosuppressive agents (e.g. mycophenolate, cyclosporine, fludarabine), combination chemotherapy (e.g. cyclophosphamide plus fludarabine), and sequential chemotherapy (e.g. cyclophosphamide-azathioprine), immunological reconstitution using intensive cytoreductive chemotherapy (with or without stem cell rescue), co-stimulatory molecule inhibition (e.g. humanized anti-CD154 monoclonal antibody, CTLA4-Ig). Gene therapy remains an attractive prospect, but its feasibility clearly depends on the further definition of lupus-promoting genes and the availability of methods to establish stable expression of disease-corrective genes in the appropriate lymphoid cells.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
4. |
The nephropathies of HIV infection: pathogenesis and treatment |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 117-122
Paul Kimmel,
Preview
|
|
摘要:
Several different renal syndromes have been reported in patients with HIV infection. Patient characteristics and a syndrome approach may help the clinician formulate a tentative diagnosis, but a renal biopsy is necessary to make a firm diagnosis in patients with chronic renal disease in the setting of HIV infection. The pathogenesis of the HIV nephropathies can teach us much about the pathophysiology of common renal problems such as IgA nephropathy, immune complex glomerulonephritis, focal segmental glomerulosclerosis, and diabetic renal disease. HIV-associated renal disease may be the result of the interaction of the expression of specific HIV genes in patients with distinct genetic susceptibilities to disease in particular environments. New treatment approaches have provided hope for patients with classic HIV-associated nephropathy.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
5. |
Calcimimetic agents and the calcium-sensing receptor |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 123-132
Jack Coburn,
Hla Maung,
Preview
|
|
摘要:
Blood ionized extracellular calcium is closely regulated. To accomplish this, a hormone-like receptor that is responsive to extracellular ionized calcium regulates both the secretion of parathyroid hormone and the excretion of urinary calcium (as well as other cellular processes). Several hereditary disorders have mutations that cause either loss or gain of function of the calcium-sensing receptor, and alterations of the calcium-sensing receptor may play a role in both primary and secondary hyperparathyroidism. Calcimimetics are agents that act to make the calcium-sensing receptor more sensitive to extracellular ionized calcium; thereby they suppress the secretion of parathyroid hormone. Early trials in animal models of secondary hyperparathyroidism and in patients with primary hyperparathyroidism or with uremic secondary hyperparathyroidism have shown that the first generation calcimimetic, R-568, effectively lowers parathyroid hormone levels and is well tolerated.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
6. |
The role of tubulointerstitial injury in chronic renal failure |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 133-138
Gavin Becker,
Tim Hewitson,
Preview
|
|
摘要:
Progressive renal failure results from a triad of glomerulosclerosis, tubulointerstitial fibrosis and vascular sclerosis. The mechanisms by which tubules are injured, and by which the tubular epithelial cell then excites interstitial inflammation culminating in fibroblast activation and fibrosis have become increasingly understood. Most current methods to prevent progressive glomerulosclerosis would inherently prevent tubular injury and interstitial fibrosis. The behaviour and control of the renal fibroblast is being investigated, with the potential for direct interference with its functions.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
7. |
Recent advances in the understanding and management of primary vesicoureteral reflux and reflux nephropathy |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 139-142
Elaine Kamil,
Preview
|
|
摘要:
Vesicoureteral reflux and reflux nephropathy continue to be active areas of clinical investigation. There is conclusive evidence that vesicoureteral reflux is inherited. Prenatal diagnosis offers the opportunity for early recognition and intervention that may reduce the incidence of complications of vesicoureteral reflux such as pyelonephritis episodes and the development of reflux nephropathy.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
8. |
Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 143-147
Vito Campese,
Stefano Bianchi,
Roberto Bigazzi,
Preview
|
|
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
9. |
Molecular mechanisms of sodium transport inhibition in proximal tubule during acute hypertension |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 149-156
Clara Magyar,
Alicia McDonough,
Preview
|
|
摘要:
Acute hypertension provokes a rapid decrease in proximal tubule salt and water reabsorption that increases the levels of sodium chloride at the macula densa, the error signal to increase arteriolar resistance to autoregulate renal blood flow and glomerular filtration rate, and contributes to pressure natriuresis. The molecular mechanisms responsible for this critical homeostatic adjustment are beginning to be dissected: apical sodium transporters in the proximal tubule are redistributed out of the brush border to intermicrovillar and endosomal stores and sodium pump activity is inhibited. These responses are strikingly similar to the cellular responses to parathyroid hormone, and are mediated by similar signalling pathways.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
10. |
Renal endothelin in hypertension |
|
Current Opinion in Nephrology and Hypertension,
Volume 9,
Issue 2,
2000,
Page 157-164
David Pollock,
Preview
|
|
摘要:
Due to the potent vasoconstrictor action of endothelin-1 and its synthesis throughout the vasculature and other tissues, most investigators believe that it is an active participant in the pathogenesis of hypertension. However, the autocrine and paracrine nature of the endothelin system has made its role difficult to define. In recent years, it has become apparent that endothelin-1 contributes to the regulation of renal salt and water excretion and that it is a major contributor to the hypertension associated with salt-dependency. Evidence suggests that endothelin-1 within the renal medulla is activated in conditions of salt loading and inhibits reabsorption of sodium in a nitric oxide-dependent manner. Blockade of endothelin A receptors lowers arterial pressure in animal models of salt-dependent hypertension. Furthermore, circulating levels of endothelin-1 are generally higher in African-Americans compared to white Americans as is the prevalence of salt-dependent hypertension. Therefore, it would appear that use of endothelin A-selective receptor antagonists should be targeted to those individuals at risk for salt-dependent hypertension. Blockade of endothelin B receptors would not be desirable because of their important role in eliminating a salt load.
ISSN:1062-4821
出版商:OVID
年代:2000
数据来源: OVID
|
|